Effect of Preoperative Hormonal Therapy in Hypospadias Surgery: Evaluation of the current practice at the Pediatric surgery Clinic, Clinical Center University of Sarajevo
Iranian Journal of Pediatric Surgery,
Vol. 5 No. 1 (2019),
15 June 2019
Introduction:The most common congenital abnormality of the penis is hypospadias. Although the main treatment is surgical; hormone therapy with dihydrotestosterone is also used.
Materials and Methods: This randomized clinical trial was carried out between January 2012 and December 2017 on 79 children with hypospadias (in the Clinic of Pediatric Surgery, Clinical Centre University of Sarajevo). Their mean age was 38.2±2.8 months. GroupI included 36 children whom were treated with 2.5% dihydrotestosterone gel which was applied twice a day to the penile shaft and glans for one month prior to surgery. GroupII included 43 children whom did not receive any treatment preoperatively.
Results: Mean age of patients in group I was 37.3±6.3 months and in group
II it was 39.1±5.9 months which were comparable. Complications occurring postoperatively were: urethrocutaneous fistula in 6 patients (13.9%) in group II, versus 1 patient (2.7%) in group I. There were 2 patients with meatalstenosis in group II (4.7%), and 3 (8.3%) in group I. Finally, there was a significant difference (p<0.05) between the overall reoperation rates between groups (p<0.05).
Conclusion: Pretreatment with 2.5% dihydrotestosterone transdermal gel before hypospadias repair is beneficial in decreasing complication rates.
Hohenfellner R: Hypospadie. AktUrol 1995;26:153-8.
Kaya C, Bektic J, Radmayr C, et al: The efficacy of dihydrotestosterone transdermal gel before primary hypospadias surgery: a prospective, controlled, randomized study. J Urol 2008;179(2):684-8.
Nerli RB, Koura A, Prabha V, et al: Comparison of topical versus parenteral testosterone in children with microphallic hypospadias. PediatrSurgInt 2009;25(1):57-9.
Bastos AN, Oliveira LR, Ferrarez CE, et al: Structural study of prepuce in hypospadiasedoes topical treatment with testosterone produce alterations in prepuce vascularization? JUrol 2011;185(Suppl. 6): 2474-8.
Chalapathi G, Rao KL, Chowdhary SK, et al: Testosterone therapy in microphallic hypospadias: topical or parenteral. J PediatrSurg 2003; 38: 221-223.
Wilson JD, Walker JD: The conversion of testosterone to 5alpha-androstan-17 beta-ol-3-one (dihydrotestosterone) by skin slices of man. J Clin Invest 1969; 48: 371.
Asgari SA, Safarinejad MR, Poorreza F, et al: The effect of parenteral testosterone administration prior to hypospadias surgery: A prospective, randomized and controlled study. J Pediatr Urol 2015;11:143.e1-e6.
Mureau MA, Slijper FM, Nijman RJ, et al: Psychosexual adjustment of children and adolescents after different types of hypospadias surgery: a norm-related study. J Urol 1995; 154: 1902.
Luo CC, Lin JN, Chiu CH et al: Use of parenteral testosterone prior to hypospadias surgery. PediatrSurgInt 2003; 19: 82-84.
Snodgrass WT, Villanueva C, Granberg C, et al: Objective use of testosterone reveals androgen insensitivity in patients with proximal hypospadias. J PediatrUrol 2014; 10: 118-122.
Blethen SL, Gaines S, Weldon V: Comparison of predicted and adult heights in short boys: effects of androgen therapy. Pediatr Res 1984; 18:467–470.
- Abstract Viewed: 83 times
- PDF Downloaded: 42 times